Biotesserae Camunity

company

About

Biotesserae Camunity develops a nanobody-based platform designed for canine cancer treatments.

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$100K
Industries
Biotechnology,Health Care,Medical
Founded date
Oct 25, 2016
Operating Status
Active

Biotesserae Camunity is a nanobody-based platform for the production of a new class of therapeutics for canine cancer. The company was formed by Chris Cebra, chair of the Department of Clinical Sciences, and colleagues Shay Bracha, Dan Mourich, and Carl Ruby.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100K
Biotesserae Camunity has raised a total of $100K in funding over 2 rounds. Their latest funding was raised on Jan 6, 2022 from a Pre-seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 6, 2022 Pre-seed $100K 1 EXPERT DOJO Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Biotesserae Camunity is funded by 1 investors. EXPERT DOJO are the most recent investors.
Investor Name Lead Investor Funding Round
EXPERT DOJO Yes Pre-seed